cardiovascular disease

Pharma Matthew Herper

STAT Plus: After its drug was shown to prevent heart attacks, what’s next for Esperion?

Health Damian Garde and Matthew Herper

STAT Plus: Heart repair, risky genes, and AI: the buzz from a giant cardiovascular conference

Pharma Matthew Herper

STAT Plus: Esperion Therapeutics’ statin alternative reduces heart attack risk. Is that enough to save the company?

Health Matthew Herper

One type of artificial sweetener may increase heart attack risk, preliminary study says

Health Tech Ambar Castillo

STAT Plus: Tools to predict stroke risk work less well for Black patients, study finds

Health Tech Lizzy Lawrence

STAT Plus: A device restored hand movement for two stroke survivors. Researchers want to take it mainstream

First Opinion Nisha Parikh and Alison Cowan

Pregnancy complications heighten heart risks in later life. It’s time to pay attention

Health Elaine Chen

Seizure drug offers hope of expanding the pool of donor hearts

Health Katherine Harmon Courage

Racism leads to troubled sleep — and it’s putting Black Americans’ heart health at risk

Health Tech Mario Aguilar

STAT Plus: Apple scores victory in dispute over heart monitoring technologies in Apple Watch

Health Tech Mario Aguilar

STAT Plus: ‘Who is the real pioneer?’: Apple and AliveCor go head-to-head over crucial heart monitoring tech for smartwatches

Health Katherine Harmon Courage

A simple screening question could help millions of women prevent cardiovascular disease. Why aren’t we using it?

Health Usha Lee McFarling

Brains of Black Americans age faster, study finds, with racial stressors a likely factor

Health Jayne Williamson-Lee

Women and men are different, cardiovascular edition

Health Isabella Cueto

Coffee? Keto? Olive Oil? New tool surfaces science behind diet and habits

Biotech Damian Garde

STAT Plus: Data show strong results for Alnylam therapy for heart disease, but magnitude of benefit will stir debate

Health Tech Mario Aguilar

STAT Plus: An ambitious stroke prevention study tests the Apple Watch’s promise in health

Health Katherine Gilyard

Study: religious practice, spirituality can improve Black Americans’ cardiovascular health

In the Lab Elizabeth Cooney

New research digs into the genetic drivers of heart failure, with an eye to precision treatments

Biotech Damian Garde

STAT Plus: Alnylam therapy for increasingly common heart disease succeeds in closely watched trial

The Readout LOUD Damian Garde and Adam Feuerstein

Listen: CRISPR for the heart, biotech’s recovery, & what it means to be a ‘hot girl’

Biotech Matthew Herper and Megan Molteni

STAT Plus: Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease

Biotech Matthew Herper

STAT Plus: New analysis of Amarin’s Vascepa resurrects big questions about effectiveness

Health Akila Muthukumar Valliammai

STAT Plus: Popular drug may have new benefit in men with diabetes, but not women, study shows

Pharmalot Ed Silverman

STAT Plus: High blood pressure pills are costly — but also hard to find — in some lower-income countries

Matt's Take Matthew Herper

STAT Plus: Robert Califf is a fervent believer in data. At the FDA, will that be enough?

Special Report Damian Garde

STAT Plus: It’s the cardiovascular version of Alzheimer’s — and, for a biotech with a promising drug, it could be a windfall

Health Lindsey Tanner — Associated Press

Advice shifting on aspirin use for preventing heart attacks

Health Elizabeth Cooney

‘Information alone is not enough’: New Jackson Heart Study leader commits to putting research into action